Abivax S.A.
Abivax S.A. (ABVX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABVX · as of Jun 8, 2026
Key Statistics
Explore Abivax S.A. Data
abvx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The ABVX analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $131.22, representing +29.24% upside from the current price of $101.53.
Competitors & Peers
abvx competitorsABVX
AXSM
CORT
CYTK
HALO
JAZZStock Performance
Full HistoryAbout Abivax S.A.
Abivax S.A. operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases.…
what is abivax s.a. · abvx stock overview · abivax s.a. company profile · who is abivax s.a. ceo · abvx NASDAQ · abivax s.a. headquarters · abivax s.a. business segments
About Stock Overview & Key Data
Abivax S.A. (ABVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 20, 2023. As of the latest trading session, ABVX stock price is $101.53, with a market capitalization of $6.7B. The stock has returned +1201.67% over the past 12 months and -24.71% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Abivax S.A. stock is Buy, with an average 12-month price target of $131.22. In fiscal year 2025, Abivax S.A. reported revenue of — and net income of -$336.1M. For detailed data — including Abivax S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Abivax S.A. (ABVX) stock price is $101.53. The stock is traded on NASDAQ under the ticker symbol ABVX. The 52-week range is $5.69 – $148.83.